SCHEMBL26077377

SCHEMBL26077377

COC(=O)c1cc(Oc2ccc(N3CCCCC3)nc2)nc(-c2cc(F)cc(Br)c2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FURIN P09958 6/20 0.39
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CSF1R P07333 1/20 0.37
▸ DAPK1 P53355 1/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ ABL1 P00519 1/20 0.35
▸ KCNQ3 O43525 1/20 0.35
▸ KCNQ2 O43526 1/20 0.35
▸ SCN9A Q15858 1/20 0.35
▸ SLC6A9 P48067 1/20 0.35
▸ SLC6A5 Q9Y345 1/20 0.35
▸ HPGD P15428 1/20 0.35
▸ ADK P55263 1/20 0.35
▸ ZAP70 P43403 1/20 0.35
▸ GPR119 Q8TDV5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21551014 0.91 FURIN (0.40) FURINNPC1RAB9AKMT2ATSHR
SCHEMBL26077378 0.91 SCD (0.39) FURINKCNQ3KCNQ2SCN9ASLC6A9
SCHEMBL21551516 0.88 GPR119 (0.42) FURINGPR119CRBN
SCHEMBL29890753 0.88 GPR119 (0.42) FURINGPR119CRBN
SCHEMBL30931835 0.88 GPR119 (0.42) FURINGPR119CRBN
SCHEMBL26077221 0.85 FURIN (0.51) FURINNPC1RAB9AKMT2ACSF1R
SCHEMBL26077380 0.82 FURIN (0.41) FURINSCN9AADK
SCHEMBL26077381 0.79 FURIN (0.41) FURINNPC1RAB9AKMT2AADK
SCHEMBL21551594 0.79 CKS1B (0.44) FURINGPR119CRBN
SCHEMBL26077220 0.79 GPR119 (0.51) FURINNPC1RAB9AKMT2ACSF1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11773078-B2 Furin inhibitors GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2023-10-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11773078-B2 Furin inhibitors FURIN, TGFB1, PCSK7 FURIN 1/4885NPC1 250/4885RAB9A 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback